Cargando…
Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
OBJECTIVE: To compare extra-lipid effects of statins and fibrates in relation to the baseline metabolic status of patients. RESEARCH DESIGN AND METHODS: The study involved a group of 242 metabolic syndrome patients with or without pre-diabetes and randomized to atorvastatin, fenofibrate, or placebo....
Autores principales: | Krysiak, Robert, Gdula-Dymek, Anna, Bachowski, Ryszard, Okopień, Bogusław |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945172/ https://www.ncbi.nlm.nih.gov/pubmed/20587704 http://dx.doi.org/10.2337/dc10-0272 |
Ejemplares similares
-
Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
por: Pruski, Maciej, et al.
Publicado: (2009) -
The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
por: Krysiak, Robert, et al.
Publicado: (2011) -
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020) -
Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021) -
The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)